OLAMLO HCT 40/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/5/12.5 mg film-coated tablet blister pack - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
OLAMLO HCT 40/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/5/12.5 mg film-coated tablet blister pack AUST R: 312003Active ingredients:
amlodipine besilate
hydrochlorothiazide
olmesartan medoxomil
Dosage form: Tablet, film coated
Sponsor: Accord Healthcare Pty Ltd
Phone: 1800 222 673
|
From 14 Sep 2026 to 31 Jan 2027
|
Shortage status: Current
Availability: Unavailable
Reason: Unexpected increase in consumer demand
Management action: An alternative brand is available.
|